Yuanyuan Tu

657 total citations
23 papers, 511 citations indexed

About

Yuanyuan Tu is a scholar working on Ophthalmology, Molecular Biology and Neurology. According to data from OpenAlex, Yuanyuan Tu has authored 23 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Ophthalmology, 13 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Yuanyuan Tu's work include Retinal Diseases and Treatments (14 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Advanced Glycation End Products research (3 papers). Yuanyuan Tu is often cited by papers focused on Retinal Diseases and Treatments (14 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Advanced Glycation End Products research (3 papers). Yuanyuan Tu collaborates with scholars based in China and United States. Yuanyuan Tu's co-authors include Manhui Zhu, Xiaojuan Liu, E Song, Linling Zhu, Zhenzhen Wang, Shu Du, Yang Guo, Yuting Zhang, Lele Li and Kun Wang and has published in prestigious journals such as Science Advances, Advanced Science and Journal of Cellular Physiology.

In The Last Decade

Yuanyuan Tu

23 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuanyuan Tu China	14	251	191	74	66	61	23	511
Natalia Martínez‐Gil Spain	12	391 1.6×	231 1.2×	87 1.2×	41 0.6×	53 0.9×	22	616
Zhilan Yuan China	13	196 0.8×	223 1.2×	66 0.9×	40 0.6×	51 0.8×	33	509
Tracy S. Obertone United States	14	354 1.4×	76 0.4×	85 1.1×	86 1.3×	59 1.0×	18	661
Xu Zha China	9	365 1.5×	120 0.6×	104 1.4×	45 0.7×	74 1.2×	24	644
Limin Gu China	8	222 0.9×	263 1.4×	81 1.1×	39 0.6×	70 1.1×	9	502
Hongjun Du China	15	426 1.7×	334 1.7×	113 1.5×	67 1.0×	54 0.9×	36	758
Xiaorui Yu China	15	429 1.7×	110 0.6×	84 1.1×	46 0.7×	51 0.8×	28	706
Kanako Izumi‐Nagai Japan	14	405 1.6×	558 2.9×	64 0.9×	112 1.7×	79 1.3×	15	994
Lincoln Biswas United Kingdom	15	269 1.1×	116 0.6×	27 0.4×	34 0.5×	25 0.4×	19	543
Kimberly Dine United States	16	290 1.2×	128 0.7×	16 0.2×	53 0.8×	98 1.6×	31	651

Countries citing papers authored by Yuanyuan Tu

Since Specialization

Citations

This map shows the geographic impact of Yuanyuan Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyuan Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyuan Tu more than expected).

Fields of papers citing papers by Yuanyuan Tu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanyuan Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyuan Tu. The network helps show where Yuanyuan Tu may publish in the future.

Co-authorship network of co-authors of Yuanyuan Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanyuan Tu. A scholar is included among the top collaborators of Yuanyuan Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanyuan Tu. Yuanyuan Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Junliang, Yang Zhou, Jia Zeng, et al.. (2025). Dynamically covalent lipid nanoparticles mediate CRISPR-Cas9 genome editing against choroidal neovascularization in mice. Science Advances. 11(28). eadj0006–eadj0006. 2 indexed citations

Zhou, Zilin, Li‐Zhong Sun, Yuanyuan Tu, et al.. (2024). Exploring Naturally Tailored Bacterial Outer Membrane Vesicles for Selective Bacteriostatic Implant Coatings. Advanced Science. 11(39). e2405764–e2405764. 8 indexed citations

Tu, Yuanyuan, et al.. (2024). Tocilizumab attenuates choroidal neovascularization by regulating macrophage polarization through the IL-6R/STAT3/VEGF pathway. Heliyon. 10(6). e27893–e27893. 2 indexed citations

Li, Meng, Yuanyuan Tu, Menglin Fan, et al.. (2023). An engineered dual-functional peptide with high affinity to demineralized dentin enhanced remineralization efficacy in vitro and in vivo. Journal of Materials Chemistry B. 11(23). 5170–5184. 4 indexed citations

Tu, Yuanyuan, et al.. (2022). [Meta-analysis of leg length discrepancy after robot-assisted and traditional total hip arthroplasty].. PubMed. 36(5). 561–566. 2 indexed citations

Ji, Na, Yang Guo, Songbai Liu, et al.. (2022). MEK/ERK/RUNX2 Pathway-Mediated IL-11 Autocrine Promotes the Activation of Müller Glial Cells during Diabetic Retinopathy. Current Eye Research. 47(12). 1622–1630. 6 indexed citations

Wang, Ying, Manhui Zhu, Yang Guo, et al.. (2021). Shikonin alleviates choroidal neovascularization by inhibiting proangiogenic factor production from infiltrating macrophages. Experimental Eye Research. 213. 108823–108823. 10 indexed citations

Zhu, Manhui, Ying Wang, Linling Zhu, et al.. (2021). Crosstalk Between RPE Cells and Choroidal Endothelial Cells via the ANXA1/FPR2/SHP2/NLRP3 Inflammasome/Pyroptosis Axis Promotes Choroidal Neovascularization. Inflammation. 45(1). 414–427. 14 indexed citations

Tu, Yuanyuan, Lele Li, Linling Zhu, et al.. (2021). Geniposide Attenuates Hyperglycemia‐Induced Oxidative Stress and Inflammation by Activating the Nrf2 Signaling Pathway in Experimental Diabetic Retinopathy. Oxidative Medicine and Cellular Longevity. 2021(1). 9247947–9247947. 46 indexed citations

10.

Wang, Ying, Quan Li, Xiaoyan Ji, et al.. (2021). The HIF‐1α/p53/miRNA‐34a/Klotho axis in retinal pigment epithelial cells promotes subretinal fibrosis and exacerbates choroidal neovascularization. Journal of Cellular and Molecular Medicine. 25(3). 1700–1711. 24 indexed citations

11.

Wang, Ying, et al.. (2021). The P300/XBP1s/Herpud1 axis promotes macrophage M2 polarization and the development of choroidal neovascularization. Journal of Cellular and Molecular Medicine. 25(14). 6709–6720. 24 indexed citations

12.

Ji, Xiaoyan, Yuanyuan Tu, Kun Wang, et al.. (2020). MLN4924 inhibits hedgehog signaling pathway and activates autophagy to alleviate mouse laser-induced choroidal neovascularization lesion. Biomedicine & Pharmacotherapy. 130. 110654–110654. 7 indexed citations

13.

Liu, Xiaojuan, Aisong Guo, Yuanyuan Tu, et al.. (2020). Fruquintinib inhibits VEGF/VEGFR2 axis of choroidal endothelial cells and M1-type macrophages to protect against mouse laser-induced choroidal neovascularization. Cell Death and Disease. 11(11). 1016–1016. 20 indexed citations

14.

Wang, Jun, Zhuo Chen, Liping Yang, et al.. (2020). Estrogen induces IDO expression via TGF‑β in chorionic villi and decidua during early stages of pregnancy. International Journal of Molecular Medicine. 46(3). 1186–1196. 14 indexed citations

15.

Liu, Xiaojuan, Yuanyuan Tu, Xiaolei Sun, et al.. (2020). Dysfunctional Nurr1 promotes high glucose-induced Müller cell activation by up-regulating the NF-κB/NLRP3 inflammasome axis. Neuropeptides. 82. 102057–102057. 36 indexed citations

16.

Du, Jingxia, Ying Wang, Yuanyuan Tu, et al.. (2020). A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS/TXNIP/NLRP3 inflammasome axis in retinal Müller cells. Experimental Eye Research. 196. 108065–108065. 44 indexed citations

17.

Tu, Yuanyuan, Manhui Zhu, Zhenzhen Wang, et al.. (2020). Melatonin inhibits Müller cell activation and pro‐inflammatory cytokine production via upregulating the MEG3/miR‐204/Sirt1 axis in experimental diabetic retinopathy. Journal of Cellular Physiology. 235(11). 8724–8735. 54 indexed citations

18.

Tu, Yuanyuan, Bai Qin, Kun Wang, et al.. (2020). Long non-coding RNA MEG3 promotes cataractogenesis by upregulating TP53INP1 expression in age-related cataract. Experimental Eye Research. 199. 108185–108185. 19 indexed citations

19.

Li, Lele, Manhui Zhu, Bai Qin, et al.. (2019). Brivanib, a multitargeted small‐molecule tyrosine kinase inhibitor, suppresses laser‐induced CNV in a mouse model of neovascular AMD. Journal of Cellular Physiology. 235(2). 1259–1273. 22 indexed citations

20.

Tu, Yuanyuan, Ying Wang, Xun Xu, et al.. (2019). Prodrug of epigallocatechin-3-gallate alleviates choroidal neovascularization via down-regulating HIF-1α/VEGF/VEGFR2 pathway and M1 type macrophage/microglia polarization. Biomedicine & Pharmacotherapy. 121. 109606–109606. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact